To verify the association between EGFR mutations and reduced UbcH10 levels in in vivo specimens, we assessed the expression of UbcH10 in several NSCLC tissues derived from patients receiving treatment. The gene discussed is UBE2C; the disease is non-small cell lung carcinoma.